Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Tonix Pharmaceuticals Holding Corp. (TNXP)

1.47   -0.06 (-3.92%) 11-19 16:00
Open: 1.45 Pre. Close: 1.53
High: 1.66 Low: 1.45
Volume: 140,495 Market Cap: 2M
Tonix Pharmaceuticals Holding Corp is a clinical-stage pharmaceutical company dedicated to the development of pharmaceutical products to address public health challenges. Its drug development program is focused on delivering treatment for PTSD.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 1.671 - 1.687 1.687 - 1.697
Low: 1.419 - 1.438 1.438 - 1.45
Close: 1.458 - 1.489 1.489 - 1.508

Technical analysis

as of: 2019-11-19 4:30:28 PM
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 4.18     One year: 5.72
Support: Support1: 1.44    Support2: 1.20
Resistance: Resistance1: 3.58    Resistance2: 4.90
Pivot: 2.64
Moving Average: MA(5): 1.90     MA(20): 2.92
MA(100): 5.07     MA(250): 15.63
MACD: MACD(12,26): -0.63     Signal(9): -0.49
Stochastic oscillator: %K(14,3): 3.99     %D(3): 6.98
RSI: RSI(14): 29.00
52-week: High: 96.00  Low: 1.44  Change(%): -96.9
Average Vol(K): 3-Month: 10353  10-Days: 35136

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
TNXP has closed above bottom band by 5.0%. Bollinger Bands are 14.6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Tonix Pharmaceuticals (NASDAQ:TNXP) Shares Down 25.3%
Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) fell 25.3% on Friday . The company traded as low as $1.48 and last traded at $1.65, 808,300 shares traded hands during trading. An increase of 783% from the average session volume of 91,501 shares. The stock had previously closed at $2.21. A number of brokerages have weighed in on […]

The Daily Biotech Pulse: Amarin Gets Unanimous Backing For Vascepa Expansion, BeiGene's Blood Cancer Drug Gets Approval
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Nov. 14) 10X Genomics Inc (NASDAQ: TXG )(IPOed Sept. 12) 89bio Inc (NASDAQ: ETNB ) (IPOed Nov. 11) Bio-Rad Laboratories, Inc. Class A (NYSE: BIO ) Castle Biosciences Inc (NASDAQ: CSTL ) China Biologic Products Holdings Inc (NASDAQ: CBPO )(reacted to its third-quarter results) Dicerna Pharmaceuticals Inc (NASDAQ: DRNA ) Halozyme Therapeutics, Inc. (NASDAQ: HALO )(priced its debt offering) IGM Biosciences Inc (NASDAQ: IGMS ) Kodiak Sciences Inc (NASDAQ: KOD ) Novo Nordisk A/S (NYSE: NVO ) Seattle Genetics, Inc. (NASDAQ: SGEN ) XOMA Corp (NASDAQ: XOMA ) XBiotech Inc (NASDAQ: XBIT ) Down In The Dumps (Biotech stocks hitting 52-week lows on Nov. 14) Adaptimmune Therapeutics PLC – ADR (NASDAQ: ADAP ) Altimmune Inc (NASDAQ: ALT ) (reacted to its third-quarter results) Auris Medical Holding Ltd (NASDAQ: EARS ) BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX ) (priced its common stock offering) Cellectar Biosciences Inc (NASDAQ: CLRB ) China SXT Pharmaceuticals Inc (NASDAQ: SXTC ) Cleveland BioLabs, Inc.

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ Global Market
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 1.58
Shares Float (M) 1.46
% Held by Insiders 1.77
% Held by Institutions 9.96
Shares Short (K) 29
Shares Short P. Month (K)

Stock Financials

EPS -46.434
Book Value (p.s.) 6.260
PEG Ratio
Profit Margin
Operating Margin
Return on Assets (ttm) -122.4
Return on Equity (ttm) -233.4
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -17.538
Qtrly Earnings Growth
Operating Cash Flow (M) -26.79
Levered Free Cash Flow (M) -16.41

Stock Valuations

P/E -0.03
P/E Growth Ratio -0.03
P/BV 0.24
P/CF -0.09

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date 2019-11-01
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.